Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene technology based therapies in the brain.

T Wirth1, S Ylä-Herttuala

  • 1A I Virtanen Institute, University of Kuopio, Finland.

Advances and Technical Standards in Neurosurgery
|June 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RFC1-related disorders: A case series of 4-aminopyridine and acetyl-DL-leucine treatment.

Cerebellum (London, England)·2026
Same author

Training in movement disorders during neurology residency in France: A national survey on educational gaps and future perspectives.

Revue neurologique·2025
Same author

Epigenetic drug screening identifies enzyme inhibitors A-196 and TMP-269 as novel regulators of sprouting angiogenesis.

Scientific reports·2025
Same author

BMP2 gene transfer induces pericardial effusion and inflammatory response in the ischemic porcine myocardium.

Frontiers in cardiovascular medicine·2023
Same author

Supplementary orthopaedic screening for children and adolescents to prevent permanent skeletal deformities - protocol for the "OrthoKids" study.

BMC musculoskeletal disorders·2023
Same author

SproutAngio: an open-source bioimage informatics tool for quantitative analysis of sprouting angiogenesis and lumen space.

Scientific reports·2023

Gene therapy offers promising treatments for various diseases, including cancer and genetic disorders like adenosine deaminase (ADA) deficiency. Enhancing safety and targeting specific cells are key goals for advancing this medical frontier.

Area of Science:

  • Medical research
  • Biotechnology
  • Genetics

Background:

  • Gene therapy is a rapidly advancing field with significant potential for treating diseases.
  • Early applications included treating adenosine deaminase (ADA) deficiency, not solely cancer.
  • Gene therapy research spans various medical areas, including oncology, neurology, and cardiology.

Purpose of the Study:

  • To review the current state and future directions of gene therapy.
  • To highlight the importance of improving gene therapy efficiency and safety.
  • To address the critical need for targeted gene delivery to specific cells.

Main Methods:

  • Review of existing gene therapy research and clinical applications.
  • Discussion of challenges and ethical considerations in human gene therapy.

Related Experiment Videos

  • Exploration of advancements in vector technology for targeted delivery.

    • Main Results:

    • Gene therapy shows promise beyond cancer, including for genetic disorders and systemic diseases.
    • Safety concerns, exemplified by early adverse events, necessitate rigorous development.
    • Targeted gene transfer is crucial for efficacy and minimizing side effects.

    Conclusions:

    • Gene therapy holds immense potential for modern medicine, requiring continued research.
    • Improvements in safety and specificity are paramount for successful clinical translation.
    • Overcoming ethical and technical hurdles is essential for realizing gene therapy's full benefits.